Chronic Diseases

Diabetes Obesity Diabetes Management Respiratory Diseases Obesity Management Hypertension Hypertension Management Diabetes Treatment Type 2 Diabetes Cardiovascular Diseases Non-communicable Diseases Cardiovascular Health Obesity Treatment Obesity-Related Conditions Diabetes Care Metabolic Disorders Treatment Options Dementia Medical Misinformation Sickle Cell Disease Childhood Obesity Kidney Diseases Risk Predictions Alzheimer's Disease Specialty Pharmacies Diabetes Mellitus Liver Disease Demographics Autoimmune Conditions Cancer Treatment Hepatitis C Preventive Medicine Musculoskeletal Disorders Patient Care Inflammatory Diseases Management COPD Cancer Prevention Gynecological Disorders Renal Diseases Aging Population Ageing Population Liver Fibrosis Obesity-Related Diseases Neurology Weight Management Mental Health Interaction Hepatitis Delta Virus

5 ARTICLES

last wk.

Nanexa Licenses PharmaShell to Novo Nordisk in Deal Worth Up to €1.17 Billion

The agreement gives Novo Nordisk exclusive rights for up to five programs to develop monthly or quarterly long‑acting injectables and assigns development and commercialization responsibility to Novo Nordisk.

4 ARTICLES

4w ago

Eli Lilly Trades Near $1,160 as GLP-1 Sales and FDA Cardio Approval Drive Valuation

7 ARTICLES

4mo ago

New Adiposity Rules Would Label Most Americans as Obese

6 ARTICLES

5mo ago

Baron Health Care Fund Falls 6.97% in Q1, Repositions for Long-Term Growth

3 ARTICLES

7mo ago

AI Liquid Biopsy Reads cfDNA Fragmentome to Detect Early Liver Fibrosis and Cirrhosis

3 ARTICLES

7mo ago

GLP-1 Drugs Plus Healthy Habits Linked to Lower Heart Risk in Large VA Diabetes Study

4 ARTICLES

7mo ago

RFK Jr.’s ‘Sickest People’ Claim Triggers High-Profile Pushback as Reiner Cites Vaccine Policy Turmoil

4 ARTICLES

8mo ago

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

4 ARTICLES

8mo ago

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

3 ARTICLES

last yr.

ABIVAX to Present Late-Breaking Phase 3 Ulcerative Colitis Data on Oct. 6 at UEG Congress

3 ARTICLES

last yr.

Monthly Phone Coaching Sustains Weight Loss for 20 Months as Algorithmic Extra Calls Fall Short

6 ARTICLES

last yr.

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

3 ARTICLES

last yr.

Global Study Finds Nearly Half of People With Diabetes Go Undiagnosed

3 ARTICLES

last yr.

Review Finds COPD Risk Elevated in People With Schizophrenia, Even After Smoking Adjustment

6 ARTICLES

last yr.

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

Chronic Diseases

Nanexa Licenses PharmaShell to Novo Nordisk in Deal Worth Up to €1.17 Billion

Eli Lilly Trades Near $1,160 as GLP-1 Sales and FDA Cardio Approval Drive Valuation

New Adiposity Rules Would Label Most Americans as Obese

Baron Health Care Fund Falls 6.97% in Q1, Repositions for Long-Term Growth

AI Liquid Biopsy Reads cfDNA Fragmentome to Detect Early Liver Fibrosis and Cirrhosis

GLP-1 Drugs Plus Healthy Habits Linked to Lower Heart Risk in Large VA Diabetes Study

RFK Jr.’s ‘Sickest People’ Claim Triggers High-Profile Pushback as Reiner Cites Vaccine Policy Turmoil

Novo’s New GLP‑1 Pill Tests Lilly’s Lead as Investors Eye Pfizer’s Cheaper Shares

Amgen Reports Year-Long Weight-Loss Maintenance With Monthly or Quarterly MariTide Dosing

ABIVAX to Present Late-Breaking Phase 3 Ulcerative Colitis Data on Oct. 6 at UEG Congress

Monthly Phone Coaching Sustains Weight Loss for 20 Months as Algorithmic Extra Calls Fall Short

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

Global Study Finds Nearly Half of People With Diabetes Go Undiagnosed

Review Finds COPD Risk Elevated in People With Schizophrenia, Even After Smoking Adjustment

FDA Chief Criticizes Medical Establishment, Advocates Lifestyle Changes for Health

Never miss stories about

Chronic Diseases